SPDR S&P Biotech ETF
617 hedge funds and large institutions have $9.73B invested in SPDR S&P Biotech ETF in 2025 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 158 increasing their positions, 272 reducing their positions, and 102 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
35% less call options, than puts
Call options by funds: $1.47B | Put options by funds: $2.24B
42% less repeat investments, than reductions
Existing positions increased: 158 | Existing positions reduced: 272
46% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 102
Holders
617
Holding in Top 10
15
Calls
$1.47B
Puts
$2.24B
Top Buyers
| 1 | +$414M | |
| 2 | +$303M | |
| 3 | +$189M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$61.8M |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$52.8M |
Top Sellers
| 1 | -$258M | |
| 2 | -$256M | |
| 3 | -$207M | |
| 4 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$48.7M |
| 5 |
Squarepoint
New York
|
-$40.1M |